Heart Failure
3rd Edition
Published on 16. October 2025
Book
Paperback/Softback
512 pages
978-0-19-287077-3 (ISBN)
Description
Heart failure is an important and ever-expanding sub-speciality of cardiology. Many professional bodies working in healthcare are now developing specialist expertise in heart failure. With advances in medical therapy, the prognosis of the condition has improved dramatically. Whereas once heart failure was a pre-terminal diagnosis, now for many it is treatable. However, some patients remain symptomatic and at high risk of death despite maximal medical therapy.
The new edition of Heart Failure comprehensively covers all aspects necessary to manage a patient with heart failure. It gives simple, clear advice on the diagnosis, investigation, and treatment options available highlighting the current evidence-base. As part of the Oxford Specialist Handbooks in Cardiology, the chapters provide concise and objective information to guide all healthcare professionals involved in the modern day multi-disciplinary management of the syndrome. Set out logically to mirror the patient journey in heart failure, this handbook facilitates the practice of optimal evidence-based management for heart failure patients.
Ideal for trainee cardiologists, consultant cardiologists, care of the elderly and general physicians, cardiothoracic surgeons, primary care doctors, pharmacists and specialist nurses.
The new edition of Heart Failure comprehensively covers all aspects necessary to manage a patient with heart failure. It gives simple, clear advice on the diagnosis, investigation, and treatment options available highlighting the current evidence-base. As part of the Oxford Specialist Handbooks in Cardiology, the chapters provide concise and objective information to guide all healthcare professionals involved in the modern day multi-disciplinary management of the syndrome. Set out logically to mirror the patient journey in heart failure, this handbook facilitates the practice of optimal evidence-based management for heart failure patients.
Ideal for trainee cardiologists, consultant cardiologists, care of the elderly and general physicians, cardiothoracic surgeons, primary care doctors, pharmacists and specialist nurses.
More details
Series
Edition
3rd Revised edition
Language
English
Place of publication
Oxford
United Kingdom
Target group
Professional and scholarly
Edition type
Revised edition
Product notice
Paperback (trade)
Unsewn / adhesive bound
Dimensions
Height: 180 mm
Width: 106 mm
Thickness: 21 mm
Weight
345 gr
ISBN-13
978-0-19-287077-3 (9780192870773)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
Professor Roy S. Gardner is a consultant cardiologist for the Scottish National Advanced Heart Failure Service at the Golden Jubilee National Hospital in Glasgow and an honorary professor at the University of Glasgow. He has a specialist interest and active research profile in advanced heart failure, cardiac transplantation, and complex devices. He is the past chair of the British Society for Heart Failure (BSH) and was awarded a lifetime Fellowship from the society 2023. He also serves on several European Society of Cardiology (ESC) committees and was the Taskforce Coordinator for the 2021 and 2023 ESC Heart Failure Guidelines.
Professor Theresa A. McDonagh is a consultant cardiologist at King's College London. Her research interests are in clinical heart failure, in particular the epidemiology of heart failure and left ventricular dysfunction and the role of biomarkers. Prof McDonagh is currently chair of the Clinical Section of the Heart Failure Association of the ESC and clinical lead for the National Heart Failure Audit.
Dr Daniel J. Doherty is a clinical research fellow at the University of Glasgow and cardiology speciality registrar in the west of Scotland. His interests include heart failure, complex devices and heart rhythm management, and he is currently undertaking a PhD examining the use of novel biomarkers for the detection of congestion in heart failure.
Dr Niki L. Walker is a consultant cardiologist at the Scottish Adult Congenital Cardiac Service for Intervention and Cardiac Obstetrics at Golden Jubilee National Hospital. She has written numerous research works as part of the ESC.
Professor Theresa A. McDonagh is a consultant cardiologist at King's College London. Her research interests are in clinical heart failure, in particular the epidemiology of heart failure and left ventricular dysfunction and the role of biomarkers. Prof McDonagh is currently chair of the Clinical Section of the Heart Failure Association of the ESC and clinical lead for the National Heart Failure Audit.
Dr Daniel J. Doherty is a clinical research fellow at the University of Glasgow and cardiology speciality registrar in the west of Scotland. His interests include heart failure, complex devices and heart rhythm management, and he is currently undertaking a PhD examining the use of novel biomarkers for the detection of congestion in heart failure.
Dr Niki L. Walker is a consultant cardiologist at the Scottish Adult Congenital Cardiac Service for Intervention and Cardiac Obstetrics at Golden Jubilee National Hospital. She has written numerous research works as part of the ESC.
Author
Consultant Cardiologist, Scottish National Advanced Heart Failure Service, Golden Jubilee National Hospital, Clydebank, and Honorary Professor, University of Glasgow, UK
Consultant Cardiologist, King's College Hospital, London and Professor of Heart Failure King's College, London, UK
Clinical Research Fellow, University of Glasgow Cardiology Speciality Registrar, UK
Consultant Cardiologist, Scottish Adult Congenital Cardiac Service, Golden Jubilee National Hospital, Clydebank, UK
Content
Section I - General Introduction
1: Definition of heart failure: basic epidemiology and pathophysiology
Section II - Chronic Heart Failure
2: Diagnosis and investigation
3: Estimating prognosis
4: Non-pharmacological management
5: Pharmacological management
6: Device therapy
7: Revascularisation
8: Cardiac transplantation
9: Mechanical circulatory support
Section III - Heart failure and co-morbid/special conditions
10: The patient with heart failure and angina
11: The patient with heart failure and arrhythmias
12: The patient with heart failure and arthritis
13: The patient with heart failure and cancer
14: The patient with heart failure and cardiomyopathy
15: The patient with heart failure and congenital heart disease
16: The patient with heart failure and diabetes mellitus
17: The patient with heart failure and electrolyte disorders
18: The patient with heart failure and infiltrative disease
19: The patient with heart failure and iron deficiency / anaemia
20: The patient with heart failure and myocarditis
21: The patient with heart failure and obstructive lung disease
22: The patient with heart failure and pregnancy
23: The patient with heart failure and renal dysfunction
24: The patient with heart failure and valvular disease
Section IV - Acute heart failure
25: Definition, aetiology, differing presentations and consequences
26: Management
Section V - Procedures
27: Central venous cannulation
28: Swan Ganz catheterisation
29: Cardiac biopsy
30: IABP insertion
31: Cardiopulmonary exercise testing
Section VI - Detailed pharmacology and evidence base for chronic heart failure
32: ACE inhibitors
33: ARNI
34: ARBs
35: Beta-adrenoreceptor antagonists
36: Mineralocorticoid receptor antagonists
37: SGLT2 inhibitors
38: Diuretics and aquaretics
39: Rate limiting agents
40: Inotropes and vasopressors
41: Vasodilators
Section VI - Multiprofessional heart failure care
42: Heart failure services
43: Palliative care
1: Definition of heart failure: basic epidemiology and pathophysiology
Section II - Chronic Heart Failure
2: Diagnosis and investigation
3: Estimating prognosis
4: Non-pharmacological management
5: Pharmacological management
6: Device therapy
7: Revascularisation
8: Cardiac transplantation
9: Mechanical circulatory support
Section III - Heart failure and co-morbid/special conditions
10: The patient with heart failure and angina
11: The patient with heart failure and arrhythmias
12: The patient with heart failure and arthritis
13: The patient with heart failure and cancer
14: The patient with heart failure and cardiomyopathy
15: The patient with heart failure and congenital heart disease
16: The patient with heart failure and diabetes mellitus
17: The patient with heart failure and electrolyte disorders
18: The patient with heart failure and infiltrative disease
19: The patient with heart failure and iron deficiency / anaemia
20: The patient with heart failure and myocarditis
21: The patient with heart failure and obstructive lung disease
22: The patient with heart failure and pregnancy
23: The patient with heart failure and renal dysfunction
24: The patient with heart failure and valvular disease
Section IV - Acute heart failure
25: Definition, aetiology, differing presentations and consequences
26: Management
Section V - Procedures
27: Central venous cannulation
28: Swan Ganz catheterisation
29: Cardiac biopsy
30: IABP insertion
31: Cardiopulmonary exercise testing
Section VI - Detailed pharmacology and evidence base for chronic heart failure
32: ACE inhibitors
33: ARNI
34: ARBs
35: Beta-adrenoreceptor antagonists
36: Mineralocorticoid receptor antagonists
37: SGLT2 inhibitors
38: Diuretics and aquaretics
39: Rate limiting agents
40: Inotropes and vasopressors
41: Vasodilators
Section VI - Multiprofessional heart failure care
42: Heart failure services
43: Palliative care